Citations 3

SAkuraBONSAI: A Prospective, Open-label Study of Satralizumab Investigating Novel Imaging, Biomarker, and Clinical Outcomes in Patients with Aquaporin-4-IgG-seropositive (P15.AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD) (P15-1.002)

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.402

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder

Neurology Neuroimmunology & Neuroinflammation | April 22, 2017 | Volume: 4 | Issue: 4 | Pages: No page available

10.1212/nxi.0000000000000343 | PMID 28451627

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder

JAMA Neurology | May 26, 2015 | Volume: 72 | Issue: 7 | Pages: 815

10.1001/jamaneurol.2015.0248 | PMID 26010909